PPBT

Purple Biotech
PPBT

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $134K invested in Purple Biotech in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$10.4K
2
+$2.11K
3
+$1.3K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$649
5
UBS Group
UBS Group
Switzerland
+$279

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$54.3K
KWA
2
Kingswood Wealth Advisors
California
$39.4K
BNP Paribas Financial Markets
3
BNP Paribas Financial Markets
France
$14.7K
Morgan Stanley
4
Morgan Stanley
New York
$10.7K
GI
5
GAMMA Investing
California
$10.4K
RhumbLine Advisers
6
RhumbLine Advisers
Massachusetts
$2.55K
Raymond James Financial
7
Raymond James Financial
Florida
$1.3K
Northwestern Mutual Wealth Management
8
Northwestern Mutual Wealth Management
Wisconsin
$199
SS
9
SBI Securities
Japan
$47
GRP
10
Global Retirement Partners
California
$38
EWA
11
EverSource Wealth Advisors
Alabama
$38
NSIM
12
North Star Investment Management
Illinois
$35